Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation

INTRODUCTION: Chondrosarcoma is a malignant cartilage-forming bone tumour in which mutations in IDH1 and IDH2 frequently occur. Previous studies suggest an increased dependency on glutaminolysis in IDH1/2 mutant cells, which resulted in clinical trials with the drugs CB-839, metformin and chloroquin...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterse, Elisabeth F. P., Niessen, Bertine, Addie, Ruben D., de Jong, Yvonne, Cleven, Arjen H. G., Kruisselbrink, Alwine B., van den Akker, Brendy E. W. M., Molenaar, Remco J., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931088/
https://www.ncbi.nlm.nih.gov/pubmed/29576625
http://dx.doi.org/10.1038/s41416-018-0050-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931088/
https://www.ncbi.nlm.nih.gov/pubmed/29576625
http://dx.doi.org/10.1038/s41416-018-0050-9

Ejemplares similares